Jianbin Wang

Dr. Jianbin Wang

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2018 in Viruses
Verified
Journal Article
Open access
PDF file
SFShengtao Fan
Shengtao Fan
XXXingli Xu
Xingli Xu
YLYun Liao
Yun Liao
YWYongrong Wang
Yongrong Wang
JWJianbin Wang
Jianbin Wang
QLQihan Li
Qihan Li
Herpes simplex virus type 1(HSV-1) presents a conundrum to public health worldwide because of its specific pathogenicity and clinical features. Some experimental vaccines, such as the recombinant viral glycoproteins, exhibit the viral immunogenicity of a host-specific immune response, but none of these has achieved a valid epidemiological protective efficacy in the human population. In the present study, we constructed an attenuated HSV-1 strain M3 through the partial deletion of UL7, UL41, and the latency-associated transcript (LAT) using the CRISPR/Cas9 system. The mutant strain exhibited lowered infectivity and virulence in macaques. Neutralization testing and ELISpot detection of the specific T-cell responses confirmed the specific immunity induced by M3 immunization and this immunity defended against the challenges of the wild-type strain and restricted the entry of the wild-type strain into the trigeminal ganglion. These results in rhesus macaques demonstrated the potential of the attenuated vaccine for the prevention of HSV-1 in humans.

28 March 2026 in Biological Trace Element Research
Verified
Journal Article
Closed access
JZJia-Rong Zhang
Jia-Rong Zhang
YLYi-Wen Li
Yi-Wen Li
HCHong-Xuan Chen
Hong-Xuan Chen
YLYi Luo
Yi Luo
RLRu-Ming Liu
Ru-Ming Liu
JXJian-Hui Xiao
Jian-Hui Xiao